期刊文献+

肺癌患者外周血细胞亚群及其与临床关系分析 被引量:6

Analysis of peripheral blood cell subsets in patients with lung cancer and its relationship with clinic
下载PDF
导出
摘要 目的分析肺癌患者外周血T细胞亚群及NK细胞活性的表达,研究其与肺癌患者临床分期及化疗的关系。方法分析2009年6月至2010年7月苏州大学附属第一医院收治的89例肺癌患者及30例健康体检者外周血中流式细胞仪(flowcytometry,FCM)检测的T细胞亚群及NK细胞活性及血中CEA含量。结果Ⅰ~Ⅱ期、不同病理分化级别及CEA正常范围内的肺癌患者外周血各细胞亚群分布与健康对照组无统计学差异;Ⅲ~Ⅲ期及CEA升高肺癌患者CD4+、CD4+/CD8+、CD2+8细胞比值下降(P〈0.05),CD8+、CD4+、CD2+5细胞比值升高(P〈0.05),NK细胞比例较健康对照组无统计学差异。化疗2周后患者外周血CD3+、CD4+、CD4+/CD8+、CD2+8比值降低(P〈0.01),CD8+、CD4+、CD2+5细胞比值升高(P〈0.01),NK细胞比例升高。结论肺癌患者免疫功能存在一定抑制,Ⅲ~Ⅳ期及CEA升高的患者免疫抑制更明显,化疗后患者各细胞亚群分布较前并未得到改善,甚至恶化。 Objective To assay the distribution of T cell subsets,NK cells in peripheral blood of lung cancer patients and investigate the relationshiop between them and the clinical stage and chemotheropy of lung cancer patients.Methods There were 89 lung cancer in-patients and 30 healthy examined persons from June 2009 to July 2010,and the proportions of CD+3,CD+4,CD+4/CD+8 T cells and CD+16 CD+56,CD+4 CD+25,CD+8 CD+28 cells in peripheral blood detected by flow cytometry(FCM) and the level of CEA of them were analyzed retrospectively.Results There were no significant difference of the distribution of cell subsets in periheral blood between lung cancer patients who were in phase of Ⅰ-Ⅱ stage and had different pathological differentiation of cancer and normal level of CEA and healthy controls.For lung cancer patients who were in the phase of Ⅲ~Ⅳ stage and had high level of CEA,the CD+4 and CD+8 CD+28 value and the ratio of CD+4/CD+8 decreased(P0.05),CD+8 and CD+4 CD+25 value increased(P0.05) compared to healthy controls and the activity of NK cells showed no significant difference.Two weeks after patients suffered from chemotheropy,the CD+4 and CD+8 CD+28 value and the ratio of CD+4/CD+8 decreased(P0.01),CD+8 and CD+4CD+25value increased(P0.01) and the ratio of NK cells increased(P0.01).Conclusions The immune function of Lung cancer patiens has some degree of suppression especially when they are in the phase of Ⅲ~Ⅳ stage and have high level of CEA.There is no improvements of the distribution of cell subsets after chemotherophy,and even gets worse.
出处 《临床肺科杂志》 2011年第9期1420-1422,共3页 Journal of Clinical Pulmonary Medicine
关键词 肺癌 T细胞亚群 流式细胞术 化疗 lung cancer T cell subsets flowcytometry chemotheropy
  • 相关文献

参考文献14

  • 1王桂芝,秦文华.化疗对肿瘤患者淋巴细胞亚群的影响[J].中华全科医学,2009,7(12):1307-1308. 被引量:18
  • 2徐红,毛一香,张学光,王庆才.晚期消化道肿瘤患者化疗前后T细胞亚群的变化[J].癌症,2008,27(4):418-424. 被引量:27
  • 3任秀红,刘莉,刘平平,董文川.恶性肿瘤患者T细胞亚群变化及其与肿瘤分期的关系[J].第三军医大学学报,2006,28(18):1906-1908. 被引量:38
  • 4Sudhir Gupta.Immune Homeostasis: Regulatory T Cells (Treg) and Molecules[J]. Journal of Clinical Immunology . 2008 (6)
  • 5Pittet MJ.Behavior of immune players in the tumor microenviron-ment. Current Opinion . 2009
  • 6H Ikeda,K Chamoto,T Tsuji,Y Suzuki,D Wakita,T Takeshima,T Nishimura.The critical role of type-1 innate and acquired immunity in tumor immunotherapy. Cancer Science . 2004
  • 7Ebert LM,Tan BS,Browning J,et al.The regulatory Tcell-associated transcription factor FoxP3 is expressed bytumor cells. Cancer Research . 2008
  • 8Yang S,Haluska FG.Treatment ofinelanoma with 5-flu-orouracil or dacarbazine in vitro sensitizes cells to antigen-specific CTL lysis through perforin/granzyme-and Fas-mediated pathways. J Immunol . 2004
  • 9Schiller JH,Harrington D,Belani CP,et al.Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer. New England Journal of Medicine, The . 2002
  • 10Fehervari Z,Sakaguchi S.CD4+ Tregs and immune control. The Journal of Clinical Investigation . 2004

二级参考文献34

  • 1程晓文,沈志祥.胃肠道恶性肿瘤患者外周血T细胞亚群检测的临床意义[J].诊断学理论与实践,2005,4(1):67-68. 被引量:7
  • 2Tadahiro Nozoe,Yoshihiko Maehara,Keizo Sugimachi.Preoperative sorting of circulating T lymphocytes in patients with esophageal squamous cell carcinoma: Its prognostic significance[J].World Journal of Gastroenterology,2005,11(42):6689-6693. 被引量:18
  • 3李广太,张士伟,宋学茹,钟述猷,刘政,尉建华,杨金富,米保香.妇科肿瘤患者外周血淋巴细胞亚群研究[J].中国肿瘤临床,1996,23(7):504-508. 被引量:17
  • 4Dirkx AE, Oude Egbrink MG, Kuijpers MJ, et al. Tumor angiogenesis- modulates leukocyte-vessel wall interactions in vivo by reducing endothelial adhesion molecule expression [ J ]. Cancer Res,2003 ,63 :2322.
  • 5HedIick SM, T lymphocyte receptors, fundamental immunology [ M ]. 2nd ed. Wepaul : Raven Press ,2004 : 198-199.
  • 6Meterlssian S, Kontogiannea M, Murty H, et al. Omesa-6 fatty acids can inhibit Fas-mediated apoptosis in a human colorectal carcinoma cell linc:a potential mechanism for escape from immune surveillance [J]. Int J Snrg Invcstig,2000,2:253.
  • 7Yang S, Haluska FG. Treatment of melanoma with 5-fiu-orouracil or dacarbazine in vitro sensitizes cells to antigen-specific CTL lysis through perforin/granzyme-and Fas-mediated pathways [ J]. J Immunol,2004 ,172 :4599.
  • 8Ahang M, Tang H, Guo Z, et al. Splenic stroma drives mature dendritic cells to differentiate into regulatory dendritic cells[ J]. Nat Immanol,2004,5:1124.
  • 9Chen W, Cheever M A. Donor T cells can be induced to grow and survive long term in vivo without previous host immunosuppression [J]. J Immunol, 1994,152 (10) :4767-4774.
  • 10Lotze M T, Finn O J. Recent advance in cellular immunology: implications for immunity to cancer [J]. Immunol Today, 1990, 11 (6) : 190-193.

共引文献80

同被引文献65

引证文献6

二级引证文献22

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部